EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSSSAG00000066355
Gene Symbol: DHCR24
3 Cross references
202 Possible Orthologues:

24-Dehydrocholesterol Reductase

Ensembl ID : ENSSSAG00000079608
Gene Symbol: DHCR24
4 Cross references
202 Possible Orthologues:

26s Protease Regulatory Subunit 6a

Ensembl ID : ENSSSAG00000042508
Gene Symbol: PRS6A
4 Cross references
221 Possible Orthologues:

26s Protease Regulatory Subunit 6b

Ensembl ID : ENSSSAG00000067990
Gene Symbol: PRS6B
4 Cross references
191 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 1-Like

Ensembl ID : ENSSSAG00000108879
Gene Symbol: LOC106613492
4 Cross references
208 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11

Ensembl ID : ENSSSAG00000084100
Gene Symbol: LOC106600937
4 Cross references
196 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11-Like

Ensembl ID : ENSSSAG00000120584
Gene Symbol: LOC106583882
3 Cross references
201 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b

Ensembl ID : ENSSSAG00000072465
Gene Symbol: LOC106589296
5 Cross references
214 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 12

Ensembl ID : ENSSSAG00000063958
Gene Symbol: PSD12
3 Cross references
214 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 14

Ensembl ID : ENSSSAG00000056135
Gene Symbol: PSDE
4 Cross references
205 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 2

Ensembl ID : ENSSSAG00000046393
Gene Symbol: LOC106613117
3 Cross references
215 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 6

Ensembl ID : ENSSSAG00000077709
Gene Symbol: LOC106565847
4 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).